Microbot Medical financials at a glance

+ Portfolio

The revenue of Microbot Medical is reported as 0 billion Dollars in the fiscal year 2023. The earnings were -1.05 Dollars per share in 2023, which was 13.84 lower than 2021. And about -0.00022 billion Dollars are reported as free cash flow in the financials of Microbot Medical 2023. No dividends were paid to the shareholders of the Microbot Medical stock NasdaqCM:MBOT in the financial year 2023.

$0.00M

Revenue

$-1.81

Earnings Per Share

0.00%

Gross Margin %

$0.00M

Free Cash Flow

Revenue

0.00

Earnings Per Share

-1.81

Gross Margin %

0.00

Free Cash Flow

0.00

Financials

Year	Year	TTM	2022	2021	2020	2019	2018	2017	2016
Rev.	Revenue	N/A	$0.00M	$0.00M	$0.00M	$0.00M	$0.00M	$0.00M	$0.00M
GM %	Gross Margin %	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
OM	Operating Margin	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
EPS	Earnings Per Share	$-1.15	$-1.81	$-1.59	$-1.29	$-1.72	$-2.41	$-2.70	$-6.00
Div.	Dividends	N/A	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
PR %	Payout Ratio %	0	0	0	0	0	0	0	0
Sha.	Shares	N/AM	8.13M	7.11M	7.11M	7.1M	4.31M	3M	2.42M
OCF	Operating Cash Flow	N/A	$0.00M	$0.00M	$0.00M	$0.00M	$-5.31M	$0.00M	$0.00M
FCF	Free Cash Flow	N/A	$0.00M	$0.00M	$0.00M	$0.00M	$-5.53M	$0.00M	$0.00M
FCFS	Free Cash Flow Per Share	$-1.00	$-1.60	$-1.33	$-1.03	$-1.56	$-1.84	$-1.64	$-0.07

Microbot Medical financials at a glance

Financials

Discover